Antileukaemic and nephrotoxic properties of platinum compounds.
D058186:Acute Kidney Injury / Q000139:chemically induced*; D000588:Amines / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002712:Chlorides / Q000627:therapeutic use; D004847:Epithelial Cells; D005260:Female; D000882:Haplorhini; D007274:Injections, Intraperitoneal; D007684:Kidney Tubules / Q000473:pathology; D007945:Leukemia, Lymphoid / Q000188:drug therapy* / Q000401:mortality; D007951:Leukemia, Myeloid / Q000188:drug therapy* / Q000401:mortality; D007958:Leukocyte Count; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D008928:Mitochondria / Q000187:drug effects; D010984:Platinum / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats; D014511:Uremia / Q000139:chemically induced
D000588:Amines; D000970:Antineoplastic Agents; D002712:Chlorides; D010984:Platinum